Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROSIGLITAZONE Cause Pulmonary oedema? 235 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 235 reports of Pulmonary oedema have been filed in association with ROSIGLITAZONE. This represents 0.5% of all adverse event reports for ROSIGLITAZONE.

235
Reports of Pulmonary oedema with ROSIGLITAZONE
0.5%
of all ROSIGLITAZONE reports
48
Deaths
226
Hospitalizations

How Dangerous Is Pulmonary oedema From ROSIGLITAZONE?

Of the 235 reports, 48 (20.4%) resulted in death, 226 (96.2%) required hospitalization, and 1 (0.4%) were considered life-threatening.

Is Pulmonary oedema Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROSIGLITAZONE. However, 235 reports have been filed with the FAERS database.

What Other Side Effects Does ROSIGLITAZONE Cause?

Myocardial infarction (17,018) Cardiac failure congestive (15,085) Cerebrovascular accident (7,899) Coronary artery disease (4,982) Acute myocardial infarction (2,437) Cardiac disorder (1,732) Coronary arterial stent insertion (1,698) Coronary artery bypass (1,181) Chest pain (990) Myocardial ischaemia (970)

What Other Drugs Cause Pulmonary oedema?

ADALIMUMAB (1,196) MACITENTAN (1,019) SACUBITRIL\VALSARTAN (958) DASATINIB (873) TREPROSTINIL (866) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (783) AMLODIPINE (774) LENALIDOMIDE (706) FUROSEMIDE (571) IBRUTINIB (494)

Which ROSIGLITAZONE Alternatives Have Lower Pulmonary oedema Risk?

ROSIGLITAZONE vs ROSUVASTATIN ROSIGLITAZONE vs ROSUVASTATIN\ROSUVASTATIN ROSIGLITAZONE vs ROTIGOTINE ROSIGLITAZONE vs ROXADUSTAT ROSIGLITAZONE vs ROXICODONE

Related Pages

ROSIGLITAZONE Full Profile All Pulmonary oedema Reports All Drugs Causing Pulmonary oedema ROSIGLITAZONE Demographics